Therapeutic implications of patterns of recurrence in cancer of the uterine cervix
- PMID: 116764
- DOI: 10.1002/1097-0142(197912)44:6<2354::aid-cncr2820440653>3.0.co;2-j
Therapeutic implications of patterns of recurrence in cancer of the uterine cervix
Abstract
Five hundred twenty-six patients with invasive cervical cancer, treated at the University of Kentucky from 1964 to 1976, were followed 2--12 years after therapy. One hundred and sixty patients (31%) developed tumor recurrence. Recurrent cancer was noted with 1 year after therapy in 58% of patients and within 2 years of treatment in 76% of patients. Only 6% of patients with recurrent cervical cancer survived 3 or more years. Stage of disease, cell type, lesion size, and the presence of lymph vascular space invasion by tumor cells were all shown to be prognostically significant. The addition of extrafascial hysterectomy to radiation therapy significantly decreased the incidence of recurrence in stage IB cervical tumors 5 cm or more in diameter. Analysis of this data suggests that radical hysterectomy and pelvic lymphadenectomy is as effective as irradiation only in the treatment of large cell squamous carcinomas 2 cm or less in diameter.
Similar articles
-
Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.Gynecol Oncol. 2001 Jul;82(1):88-93. doi: 10.1006/gyno.2001.6204. Gynecol Oncol. 2001. PMID: 11426967
-
A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.Gynecol Oncol. 2000 Nov;79(2):289-93. doi: 10.1006/gyno.2000.5935. Gynecol Oncol. 2000. PMID: 11063659
-
Preoperative radiation therapy followed by extrafascial hysterectomy in patients with stage II endometrial carcinoma.Cancer. 1991 Sep 15;68(6):1261-4. doi: 10.1002/1097-0142(19910915)68:6<1261::aid-cncr2820680614>3.0.co;2-v. Cancer. 1991. PMID: 1873779
-
Cervical cancer: combined modality therapy.Cancer J. 2001 Jul-Aug;7 Suppl 1:S47-50. Cancer J. 2001. PMID: 11504285 Review.
-
[Metastatic mechanisms of uterine malignancies and therapeutic consequences].Pathologe. 2016 Nov;37(6):549-556. doi: 10.1007/s00292-016-0243-z. Pathologe. 2016. PMID: 27757531 Review. German.
Cited by
-
The Value of Whole-Tumor Texture Analysis of ADC in Predicting the Early Recurrence of Locally Advanced Cervical Squamous Cell Cancer Treated With Concurrent Chemoradiotherapy.Front Oncol. 2022 May 20;12:852308. doi: 10.3389/fonc.2022.852308. eCollection 2022. Front Oncol. 2022. PMID: 35669419 Free PMC article.
-
Clinical Outcomes of MRI-Guided Adaptive Brachytherapy for Each Fraction in Locally Advanced Cervical Cancer: A Single Institution Experience.Front Oncol. 2022 Mar 17;12:841980. doi: 10.3389/fonc.2022.841980. eCollection 2022. Front Oncol. 2022. PMID: 35372065 Free PMC article.
-
Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities.Geburtshilfe Frauenheilkd. 2022 Feb 11;82(2):181-205. doi: 10.1055/a-1671-2446. eCollection 2022 Feb. Geburtshilfe Frauenheilkd. 2022. PMID: 35197803 Free PMC article.
-
Cancer of the cervix uteri: 2021 update.Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):28-44. doi: 10.1002/ijgo.13865. Int J Gynaecol Obstet. 2021. PMID: 34669203 Free PMC article.
-
Implications of the new FIGO staging and the role of imaging in cervical cancer.Br J Radiol. 2021 Sep 1;94(1125):20201342. doi: 10.1259/bjr.20201342. Epub 2021 May 14. Br J Radiol. 2021. PMID: 33989030 Free PMC article. Review.